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The accurate sampling of protein dynamics is an ongoing challenge despite the utilization of High
Performance Computers (HPC) systems. Utilizing only ”brute force” MD simulations requires an
unacceptably long time to solution. Adaptive sampling methods allow a more effective sampling of
protein dynamics than standard MD simulations. Depending on the restarting strategy the speed
up can be more than one order of magnitude. One challenge limiting the utilization of adaptive
sampling by domain experts is the relatively high complexity to efficiently running it on HPC
systems. We discuss how the ExTASY framework can set up new adaptive sampling strategies, and
reliably execute resulting workflows at scale on HPC platforms. Here the folding dynamics of three
small proteins is predicted with no a priori information.
I. INTRODUCTION
Molecular dynamics (MD) simulations with all-atom
force-fields allow simulating protein folding and protein
kinetics with good accuracy. Reaching biologically rele-
vant processes, such as protein folding or drug binding,
is limited mainly by the required large computational
resources and long simulation times. The long simula-
tion times can be reduced either by simulating parallel
trajectories with massively-distributed computing [1, 2]
or with special-purpose hardware [3]. Further reduction
of required computational resources or simulation times
would allow a more broad application of MD simulations.
One method of reducing both the computational re-
sources and the simulation times is adaptive sampling
[4–15]. Adaptive sampling is an iterative process, where
MD simulations from previous iterations are analyzed,
and, based on the analysis, a new iteration of relatively
short MD trajectories is initiated. The starting confor-
mations for the MD trajectories are determined in such a
way to efficiently reach a goal such as crossing rare tran-
sitions barriers, folding a protein, or recovering the dy-
namics of a macromolecule. The exact strategy where to
restart new MD simulations determines the success of the
adaptive sampling approach, and several different meth-
ods have been proposed and investigated [7–10, 15–19].
Adaptive sampling requires to use multiple parallel sim-
ulations and is therefore suitable for High Performance
Computers (HPC).
Determining the efficiency, accuracy and reliability of
a particular adaptive sampling strategy is challenging
for several reasons. Different proteins can behave differ-
ently for different adaptive sampling strategies but lim-
ited computational resources don’t allow to adaptively
∗ cecilia@rice.edu
sample a statistically significant number of proteins with
different strategies for comparison. Accurate results are
known only for a limited number of proteins. Despite
these challenges some performance analyses of adaptive
sampling strategies have been performed [5–8, 15]. The
results show that some adaptive sampling strategies are
both reliable, accurate and reach speed ups of one or
more orders of magnitude with respect to ”brute force”
MD. The larger, more complex the protein the higher
speed up is expected [15].
An important challenge in adaptive sampling simula-
tions is the complexity of performing the required com-
putational tasks efficiently on HPC platforms with het-
erogeneous software and hardware environments. This
complexity can detract from the core objective of inves-
tigating the behavior of a particular protein or the effi-
ciency of new adaptive sampling strategies. Some of the
existing frameworks which currently strive to reduce this
entry-barrier to adaptive sampling, such as HTMD[9] and
SSAGES [20], are either bound to specific software pack-
ages, algorithms, computing platforms or are not open
source. In contrast, the ExTASY[21] framework is not
coupled to specific software packages, supports multiple
adaptive sampling algorithms and is extensible, to new
algorithms and methods, while being open source and
agnostic of the HPC platform. In addition to demonstra-
tion of the scientific results that can be achieved by using
ExTASY, in this manuscript, we investigate the advan-
tages of scalability, reliability or reproducibility arising
from ExTASY framework for adaptive sampling.
II. METHODS
Many different implementations of adaptive sampling
exist but they all have in common that the previous MD
simulations are analysed and restart points for the next
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2batch of MD simulations are determined from the anal-
ysis of the sampled configurational space. The different
implementations mainly differ in the analysis step, and
they can be based on Markov State Models (MSMs) [22–
26], Diffusion Maps [27–30], likelihood-based approaches
[31], cut-based free energy profiles [32], or neural net-
works [33–35]. In this manuscript, we exemplify the us-
age of the ExTASY framework with Markov State Models
with different restarting strategies, as described in Sec-
tion II B.
A. Adaptive Sampling
In each iteration of Markov State Models-based adap-
tive sampling, all previous MD simulations are analysed.
Figure 1 is a graphical representation of the process. In
the first iteration of the adaptive sampling, the MD sim-
ulations are generated from the system starting state as
shown in Step 1.
In Step 2 all previous trajectories are analysed. In
the case of Markov State Models-based adaptive sam-
pling used here, a dimension reduction with Time-lagged
Independent Component Analysis (TICA) [36, 37] con-
verts the raw trajectories in low-dimensional trajectories.
The Koopman method [38–43] is used to reduce the non-
equilibrium effects emerging from collecting many short
MD trajectories. The resulting low-dimensional trajecto-
ries are scaled into a kinetic map [44, 45], which provides
a measure of the kinetic distance between different config-
urations. The kinetic map is then clustered with k-means
into approximately 200 microstates, the detailed values
for each protein are provided in the Supplementary In-
formation. A maximum-likelihood estimation with a de-
tailed balance constraint [22] allows to obtain an MSM
transition matrix between every pair of microstates. The
value of the lag time parameter, τ , for the TICA analysis
and for the MSM was chosen based on the results of [46],
which compared and optimized the parameter selection
for the proteins simulated here. All the analysis was per-
formed using the PyEMMA Python package [47], which
allows fast adjustments in the analysis step. The exact
parameters for the MSM construction for each protein
are listed in the Supplementary Information. All these
steps can be modified or replaced easily in the ExTASY
workflow.
The overall adaptive sampling process described in
Figure 1 can be summarized as follows:
• Start: Start with a start conformation. In the cases
presented here, we start from a configuration in the
unfolded state of a protein.
• Step 1: Generate a batch of molecular dynamics
trajectories from the selected conformations, the
parallelisation is defined by the available compu-
tational resources. This step is described in Sec-
tion II E.
Step 2
Analyse existing 
trajectories 
(MSM,...)
Start
conformations
Finish
Step 3
Goal achieved?
yes
Step 4
Select batch of 
MD restart 
conformations
Step 1
Simulate batch of 
MD trajectories 
no
FIG. 1: The flow chart shows the basic structure of
adaptive sampling. The number of starting
conformations is variable. The software and hardware
to generate the MD simulations are variable. Different
Analysis methods in Step 2 are possible, commonly
TICA [36, 37] and MSM [22] are used, but alternative
methods such as Vampnet [33] are possible. In Step 3
the goal can be also variable, from finding the whole
protein dynamics to exploring smaller-scale changes.
Step 4 allows different adaptive sampling strategies such
as the FAST method [19] or the strategies discussed in
this work.
• Step 2: Analyse the all available data as described
in Section II A, using the probabilities from the
MSM transition matrix.
• Step 3: Decide if the goal of adaptive sampling is
achieved. In this work, the goal is finding the folded
state and obtaining a converged equilibrium dy-
namics for the protein. If the goal is not achieved,
proceed to Step 4; otherwise, stop the iterative pro-
cess.
• Step 4: Select the batch of protein conformations
for Step 1 in the next iteration as described in Sec-
tion II B.
After Step 2 the adaptive sampling continues with Step
4 if the goal is not achieved. This goal could be folding
the protein, achieving a pre-determined accuracy of the
protein dynamics, but could also be manually set to finish
after a number of iterations. If the goal is not achieved
in Step 3, in Step 4 a batch of protein conformations for
the next iteration is selected as described in Section II B.
If the goal in Step 3 is achieved, the iterative adaptive
sampling finishes and the trajectories can be further anal-
ysed.
3B. Restart Strategies for Adaptive Sampling
In the ExTASY framework, the different Restart
Strategies in Step 4 in Figure 1 are easily exchangeable.
Here we use two strategies, the first one is the Macrostate
Count based strategy, further called cmacro strategy, and
the second one is the Microstate Count based strategy,
further called cmicro strategy. The cmacro strategy was
shown to be more effective in reaching the folded state
of the protein and the cmicro strategy was shown to
be more effective in exploring the whole protein land-
scape [15]. To benefit from the different strengths of the
two strategies we use in this implementation the cmacro
strategy in the initial iterations for each protein, until
the folded state is reached; then we continue the iter-
ations with the cmicro strategy to improve the accu-
racy of the protein dynamics. These two strategies do
not assume any a priori knowledge of the system except
the chemical structure of the unfolded protein, but other
adaptive sampling strategies which use additional infor-
mation about the protein can be used in the ExTASY
framework.
a. Adaptive sampling strategy cmicro One simple
restart strategy is starting new molecular dynamics tra-
jectories in the microstates which have the worse statis-
tics, that is, that have been visited the least during prior
iterations [6, 7, 9, 10]. This statement can be quanti-
fied by using the counts in the count matrix of the MSM
from Step 2, that report on how many times all previous
trajectories have visited each microstate. The probabil-
ity that any given microstate is selected in Step 4 for the
batch of restart conformations is inversely proportional to
its associated count. This strategy is less effective to fold
a protein than the cmacro strategy (described below), so
in this work the cmicro is only employed after the folded
state is found. The cmicro strategy is more effective to
explore new regions of the whole protein landscape and
to better sample the protein dynamics [15].
b. Adaptive sampling strategy cmacro Another pop-
ular restart strategy for adaptive sampling is a
macrostate-based method indicated here as cmacro. The
main advantage of this method is the faster folding of
proteins or crossing of transition barriers [15]. This ad-
vantage is achieved by using eigenvectors of the on-the-fly
MSM from Step 2 to select more restart configurations
in areas which are kinetically disconnected or less ex-
plored. In this method, the microstates of the on-the-fly
MSM are clustered into macrostates, for example with
PCCA [48]. Any microstate not connected in the main
MSM is treated as an additional macrostate. The num-
ber of macrostates can be either fixed, as in this work,
or determined based on the number of slow processes
emerging from the analysis. The macrostate count is
determined by measuring how many times any previous
trajectory has visited each macrostate. The restart con-
formations for the next iteration of adaptive sampling
are then chosen from each macrostate inversely propor-
tional to the macrostate count. Individual conformations
within a macrostate are selected inversely proportional to
the microstate count within the macrostate.
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FIG. 2: ExTASY-EnTK Integration: The diagram
illustrates the seven execution steps of an adaptive
sampling algorithm using ExTASY.
C. Tools and Software
ExTASY is a domain specific workflow system [49, 50]
for adaptive sampling algorithms on HPC platforms. Ex-
TASY exposes domain specific parameters and simula-
tion configurations, but abstracts complexities of execu-
tion management, resource acquisition and management
using RADICAL-Cybertools (RCT) [51]. RCTs are soft-
ware systems designed and implemented in accordance
with the building blocks approach [50]. Each system is in-
dependently designed with well-defined entities, function-
alities, states, events and errors. Specifically, ExTASY
uses Ensemble Toolkit (EnTK) [52] and RADICAL-Pilot
(RP) [53]. Ensemble Toolkit [52, 54] provides the ability
to create and execute ensemble-based applications with
complex coordination and communication but without
the need for explicit resource management. EnTK uses
RP [53], which provides resource management and task
execution capabilities. In this section, we describe the
ExTASY framework and how it leverages capabilities of-
fered by EnTK and RP.
1. ExTASY
ExTASY exposes configuration files to interface with
users and two components: Composer and Descriptor.
The Composer validates the user input and creates the
Resource, Execution Pattern, Simulation, and Analysis
sub-components. The Resource represents a valid re-
source description; Execution Pattern describes the num-
ber of iterations, number of simulation tasks per iteration
and number of analysis tasks per iteration; Simulation
and Analysis describe the parameters to be used for sim-
ulation and analysis tasks.
The Descriptor interfaces with Ensemble Toolkit,
the execution middleware. It consists of two sub-
4from radical.entk import Task , Stage , Pipeline
p = Pipeline ()
sim_stage = Stage ()
sim_task = Task()
sim_task.executable = <executable > #example
openmm
sim_task.arguments = <args > #example openmm args
<add other task properties >
sim_stage.add_tasks(sim_task)
ana_stage = Stage ()
ana_task = Task()
ana_task.executable = <executable > #example
pyemma
ana_task.arguments = <args > #example pyemma args
<add other task properties >
ana_stage.add_tasks(ana_task)
ana_stage.post_exec = {
’condition ’: eval_sims (),
’on_true ’: add_sims (),
’on_false ’: terminate ()
}
p.add_stages ([sim_stage , ana_stage ])
FIG. 3: Pseudocode describing the adaptive sampling
algorithm using the EnTK API
components: Resource Descriptor and Application De-
scriptor. The former converts the resource description to
a format as accepted by the middleware. The latter uses
the information from the Execution Pattern, Simulation
and Analysis sub-components to describe the complete
application to be executed.
Figure 2 presents the integration between ExTASY
and the execution middleware (EnTK). ExTASY trans-
lates the adaptive sampling application into ordered exe-
cutable tasks through a series of events: ExTASY parses
the configurational files to determine parameters to be
used and creates Resource description (event 1) and the
simulation and analysis tasks to be executed (event 2).
ExTASY then uses EnTK’s interface to describe the re-
source and application (event 3 and 4) and initiate ex-
ecution on the target resource (event 5 and 6). EnTK
executes all the simulations and analysis on the resource
(event 7).
ExTASY uses EnTK programming abstractions and
EnTK’s application programming interface (API). Ex-
TASY also uses EnTK’s capabilities to support adaptive
execution [55] by modifying the execution plan depending
upon intermediate results e.g., add more simulations and
analysis tasks. Figure 3 provides pseudo-code on how Ex-
TASY implements an adaptive sampling algorithm using
the EnTK API.
2. Ensemble Toolkit & RADICAL-Pilot
EnTK simplifies the creation and execution of applica-
tions with complex ensemble coordination and commu-
nication requirements. EnTK decouples the description
of ensemble coordination and communication from their
execution by separating three distinct concerns: (i) spec-
ification of task and resource requirements; (ii) resource
acquisition and management; and (iii) task execution.
EnTK enables the encoding of ensemble applications
by exposing an API with four components: Application
Manager, Pipeline, Stage and Task. Users specify their
application using pipelines, stages, and tasks. Users then
pass this specification and description of the target re-
source to the Application Manager. Resource description
includes properties like wall-time, number of nodes and
credentials for resource access.
The Task component is used to encapsulate an exe-
cutable and its software environment. The Stage com-
ponent contains a set of tasks without mutual depen-
dencies and that can therefore be executed concurrently.
The Pipeline component is used to describe a sequence
of stages. Description of ensemble applications in terms
of concurrency and sequentiality avoids the need to ex-
plicitly specify dependencies between tasks.
EnTK supports an explicit definition of pre and post
conditions on the execution of tasks, enabling fine-
grained adaptivity [55]. Adaptivity allows modifications
to the number, type and order of tasks to be executed
during runtime, based on intermediate results. Specifi-
cally, EnTK supports three types of adaptivity: (i) adap-
tivity in the number of tasks; (ii) adaptivity in the order
of tasks; and (iii) adaptivity in the properties of a task.
EnTK provides a simple programming model, ab-
stracts the complexities of resource and execution man-
agement, and adds only a small and well-bounded over-
head on the execution O(1000) tasks [52]. EnTK uses
a runtime system, such as RADICAL-Pilot, to acquire
the resources needed, manage task execution, as well as
provide portability across heterogeneous HPC resources.
RADICAL-Pilot: Two methods traditionally used
to execute multiple HPC tasks are: (i) each task is sched-
uled as an individual job; or (ii) use message-passing in-
terface (MPI) capabilities to execute multiple tasks as
part of a single job. The former method requires each
task to be independently executed; the latter method
is suboptimal for heterogeneous or interdependent tasks.
The pilot abstraction [56] addresses some of these lim-
itations. The pilot abstraction: (i) uses a placeholder
job without any tasks assigned to it, so as to acquire
resources; and, (ii) decouples the initial resource acquisi-
tion from task-to-resource assignment. Once the pilot is
scheduled tasks are scheduled within its spatio-temporal
resource boundaries, which allows computational tasks
to be executed directly without being queued. The pi-
lot abstraction thus supports the requirements of task-
level parallelism and high-throughput, while respecting
queue policies and constraints of HPC batch schedul-
ing. RADICAL-Pilot is an implementation of the pilot
abstraction, engineered to support scalable and efficient
launching of heterogeneous tasks across different plat-
forms.
5D. Reference Data
To show the speed up and accuracy of the adaptive
sampling method we compared the results with preexist-
ing long MD simulations of 3 small proteins, obtained on
the Anton supercomputer [57]. These proteins and the
reference data were investigated before [46, 58], allowing
us to demonstrate here the usefulness and reliability of
the ExTASY workflow. The 3 proteins are summarized in
Table I, their size is 10 to 35 residues and the folding time
within a few µs. These proteins were chosen due to their
folding time which is long enough to show the advantages
of adaptive sampling with ExTASY framework, but still
reachable with our computational resources. Only the
C-alpha coordinates are used when comparing the refer-
ence data trajectories with the results from the ExTASY
framework in this work.
TABLE I: Adaptively sampled proteins in this study
Protein PDB ID # Residues Folding Time (µs) [57] Unfolding Time (µs)
Chignolin 5AWL 10 0.6 2.2
Villin 2F4K 35 2.8 0.9
BBA 1FME 28 18 5
E. Molecular dynamics simulation
The MD simulations in this work were performed with
OpenMM 7.0.1 [59] using CUDA 7.5 on the Blue Wa-
ters supercomputer. To reproduce the same setup as in
[57] we used CHARMM22* force field [60] and the mod-
ified TIP3P water. The stepsize used was 5fs, and the
trajectories were strided to match the 0.2 ns stepsize of
the reference data. Differently from [57], we used the
Particle Mesh Ewald method for long-range electrostat-
ics due to OpenMM limitations. The protein Start states
at the beginning of the adaptive sampling were selected
randomly from the 20% of frames with the highest Root
Mean Square Deviation (RMSD) from the corresponding
crystal structure. A short energy equilibration (1-2ns)
was then performed in the NPT ensemble to create ini-
tial coordinates for the workflows. No further a priori
information was given to the ExTASY framework except
the unfolded start conformations.
In each iteration 50 OpenMM trajectories were sim-
ulated on 50 XK nodes on Blue Waters with one node
per trajectory. The length of each trajectory was 50ns
for Chignolin and Villin and 100ns for BBA. ExTASY
was used for each of the three proteins, using a total of
150 nodes at the same time. ExTASY scales to greater
number of nodes, so can be used to simulate even larger
proteins, or more proteins concurrently. Steps 2 and 4
were performed on one node on Blue Waters utilizing the
same job on Blue Waters as the MD simulations (Step
1). A job length of 48h was chosen on Blue Waters to
maximize the number of iterations executed in each job.
After all the simulations are finished, the folding times,
speed up and the accuracy of protein dynamics was de-
termined by comparing with the Anton MD simulations
starting from the selected start conformation.
III. RESULTS AND DISCUSSION
In order to analyse the efficiency of adaptive sampling,
we considered several measures. To show the complete-
ness of the exploration, we measured the fraction of ex-
plored population and considered the overlap of the ex-
plored areas with the reference dataset. This also allows
us to estimate the speed up time to solution compared to
the reference method. To analyse the accuracy of the sim-
ulated protein dynamics we compare the relative entropy
of the MSM transition matrices, and the Mean First Pas-
sage Time (MFPT) to the folded state, as detailed below.
A. Comparison of Exploration
The whole explored energy landscape of the protein
cannot be visualized due to the high dimensionality of
the raw trajectories, but the explored landscape in the
reduced TICA coordinates is shown in Figure 4. The
colored background shows the explored free energy land-
scape of the reference dataset and the shaded foreground
shows the region of this landscape explored by the adap-
tive sampling. It is clear that the whole energy landscape
of the three proteins is explored by ExTASY. The small
differences in Figure 4 could be caused by the difference
in the long-range electrostatics setup.
To show how effectively the whole protein landscape is
explored, we use the fraction of the total population ex-
plored as a function of time. Here we select all the states
which are explored at a certain time and compare with
all possible states (as obtained from the reference simula-
tions). To represent the different importance of different
states we weight the explored states with their station-
ary weight. The population of each microstate is calcu-
lated as the stationary weight of that microstate from the
MSM analysis of the reference dataset. Figure 5 reports
the comparison of the explored populations as a function
of time for the reference dataset and the ExTASY re-
sults, and shows that for all three proteins the ExTASY
exploration is about 1 order of magnitude faster than the
reference. The x-axis in Figures 5-7 is absolute simula-
tion time to show the improvement of time to solution
with ExTASY. Absolute simulation time is the length of
one trajectory in Step 1 times the number of iterations.
When all the trajectories in Step 1 are run in parallel,
the absolute simulation time shows the time to solution
independent of the used hardware. The effects of paral-
lelisation on the time to solution for adaptive sampling
was explored in [15], generally both adaptive sampling
and parallelisation decrease the time to solution.
6A)
B)
C)
FIG. 4: Exploration of the protein energy landscape in
TICA coordinates. The color background shows the
explored Free Energy landscape by the reference
dataset. The black diagonal lines on top show the
explored conformations by the adaptive sampling in this
paper. The almost perfect overlap shows that the whole
conformational landscape of the three proteins was
explored. The label shows the location of the folded
state. Individual proteins: A) Chignolin B) Villin C)
BBA
A)
B)
C)
FIG. 5: The population of explored states evolving with
absolute simulation time. Around one order of
magnitude shorter time to solution can be reached with
adaptive sampling compared to ”brute force” MD
simulations. The black vertical line shows the change
between the implementation of the cmacro adaptive
strategy for the initial iterations (left of the black line)
and the cmicro adaptive strategy (right of the black
line), described in Section II B. Individual proteins: A)
Chignolin B) Villin C) BBA
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FIG. 6: Relative entropy between the MSM transition
matrices generated during the ExTASY exploration and
from the reference data. Results for individual proteins:
A) Chignolin B) Villin C) BBA. The relative entropy
decreases with increasing number of adaptive sampling
iterations. For iteration on the left of the black vertical
line, the cmacro adaptive strategy was implemented,
while on the right of the black line the cmicro adaptive
strategy was implemented (see Section II B).
B. Comparison of Protein Dynamics
To track the convergence of protein dynamics in the
adaptive sampling workflow, one can use the relative en-
tropy [5] between the MSM transition matrix of the ref-
erence data, Pij , and the MSM transition matrix of the
analysed data, Qij . A relative entropy can be calcu-
lated between each microstate in the analysed and the
reference transition probabilities from this state. By av-
eraging the relative entropy for each state weighted by
the stationary probability over all microstates we obtain
the relative entropy between the two transition matrices.
The relative entropy D(P ||Q) is then given by
D(P ||Q) =
N∑
i,j
siPij ln
Pij
Qij
. (1)
where si is the equilibrium probability of state i. The
transition matrices Pij and Qij have to use exactly the
same dimension reduction and same clustering. As zero
counts in the transition matrices can cause divergence of
the relative entropy, a pseudo-count of 1/N (where N is
the length of the simulation) is added to each element of
the count matrices before normalizing the rows to get the
transition matrices [5]. Figure 6 shows how the relative
entropy decreases with increasing simulation time. The
relative entropy of the reference trajectory is obtained
by using the reference data up to the specified simula-
tion time. By definition, the relative entropy of the full
reference trajectory is zero. Analogously the relative en-
tropy for the ExTASY simulation data is obtained from
the data up to the specified simulation time. In Figure 6
we observe a rapid decrease of both the reference relative
entropy and ExTASY relative entropy. At the same ab-
solute simulation time ExTASY shows a smaller relative
entropy compared to the reference data.
Figure 7 shows how the Mean First Passage Time
(MFPT) from the unfolded to the folded state converges
as a function of simulation time, for the adaptive sam-
pling and reference simulations. The final MFPT ob-
tained with the two methods are comparable. These re-
sults are similar to what was obtained with the HTMD
framework [9]. One possible reason for the minor dis-
crepancies in MFPT between the results from ExTASY
adaptive sampling and the reference data is the difference
in the treatment of electrostatic.
The folded and unfolded areas of the proteins for the
MFPT calculation were defined by the RMSD relative
to the PDB crystal structures (reported in Table I). The
threshold values for the individual proteins can be found
in the Supplementary Information.
IV. CONCLUSION
We have shown that the ExTASY framework [21]
can effectively perform adaptive sampling, as exempli-
fied with different adaptive exploration strategies. The
8A)
B)
C)
FIG. 7: Mean first passage time (MFPT) from unfolded
to folded states evolving as more data is available after
more adaptive sampling iterations. The blue lines show
MFPT from the reference data. Two different adapative
sampling strategies are used, cmacro until the black
vertical line and cmicro after the black line, as
described in Section II B. Individual proteins: A)
Chignolin B) Villin C) BBA
whole free energy landscape of the 3 proteins selected for
this study was efficiently explored. The speed up com-
pared to ”brute force” molecular dynamics simulation
was about one order of magnitude. The MFPT folding
times converged to values similar to the reference values
and the relative entropy between the transition matrix
of the MSM computed during the adaptive sampling and
the MSM of the reference simulations decreases steadily
with the simulation time.
The ExTASY framework reduces the time spent by
domain experts in executing adaptive sampling in a
scalable fashion on diverse platforms. Due to the de-
sign and implementation of the ExTASY framework
[21], it can be easily modified for different proteins
or MD simulation software. It can also be easily ex-
tended to different adaptive sampling strategies and plat-
forms. All the code used in this work is available at
https://github.com/ClementiGroup/ExTASY.
V. SUPPLEMENTARY MATERIALS
See Supplementary material for the ExTASY workflow
parameters and more results for the 3 proteins.
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